ACUT Insider Trading Activity and SEC Form 4 Filings
ACUT insider trading summary
No open-market insider purchases or sales of Accustem Sciences Inc. (ACUT) have been reported on SEC Form 4 in the past 12 months.
Latest ACUT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 13, 2025 | Gabriele M Cerrone | Director | Buy | $2K (2,000 @ $1.00) |
| Jun 13, 2025 | Gabriele M Cerrone | Director | Buy | $440 (400 @ $1.10) |
| Jun 12, 2025 | Gabriele M Cerrone | Director | Buy | $7K (8,991 @ $0.83) |
| Jun 11, 2025 | Gabriele M Cerrone | Director | Buy | $11K (28,205 @ $0.39) |
| Apr 9, 2025 | Gabriele M Cerrone | Director | Buy | $2K (3,000 @ $0.67) |
| Apr 8, 2025 | Gabriele M Cerrone | Director | Buy | $23K (35,000 @ $0.67) |
| Apr 7, 2025 | Gabriele M Cerrone | Director | Buy | $23K (35,000 @ $0.65) |
| Apr 7, 2025 | Gabriele M Cerrone | Director | Buy | $11K (17,802 @ $0.61) |
| Mar 18, 2025 | Gabriele M Cerrone | Director | Buy | $45K (100,000 @ $0.45) |
| Dec 31, 2024 | Gabriele M Cerrone | Director | Buy | $38K (100,000 @ $0.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.